Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC, 2570-2571 [2019-01510]
Download as PDF
<![CDATA[
2570
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
National Fire Protection Association
(‘‘NFPA’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, NFPA has provided an
updated and current list of its standards
development activities, related technical
committee and conformity assessment
activities. Information concerning NFPA
regulations, technical committees,
current standards, standards
development and conformity
assessment activities are publicly
available at nfpa.org.
On September 20, 2004, NFPA filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on October 21, 2004 (69
FR 61869).
The last notification was filed with
the Department on October 10, 2018. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on October 22, 2018 (83 FR 53297).
Morrissette Drive, Springfield, Virginia
22152.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–01489 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: IsoSciences,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 1, 2017, IsoSciences, LLC,
340 Mathers Road, Ambler,
Pennsylvania 19002, applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Drug
code
Controlled substance
Cathinone ................................................................................................................................................................................
Methcathinone .........................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................................
Marihuana ................................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................................
Bufotenine ................................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................................
Psilocybin .................................................................................................................................................................................
Psilocyn ...................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................................
Dihydromorphine .....................................................................................................................................................................
Heroin ......................................................................................................................................................................................
Nicocodeine .............................................................................................................................................................................
Nicomorphine ...........................................................................................................................................................................
Normorphine ............................................................................................................................................................................
Thebacon .................................................................................................................................................................................
Normethadone .........................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................................
Para-Fluorofentanyl .................................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................................
Butyryl Fentanyl .......................................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................................
Thiofentanyl .............................................................................................................................................................................
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
E:\FR\FM\07FEN1.SGM
07FEN1
1235
1237
7315
7360
7370
7400
7404
7431
7432
7433
7434
7435
7437
7438
7439
9145
9200
9309
9312
9313
9315
9635
9811
9812
9813
9814
9815
9816
9821
9822
9824
9825
9830
9831
9832
9833
9834
9835
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2571
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug
code
Controlled substance
Beta-hydroxythiofentanyl .........................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................................
Amphetamine ...........................................................................................................................................................................
Methamphetamine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Oxycodone ...............................................................................................................................................................................
Hydromorphone .......................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Methadone ...............................................................................................................................................................................
Methadone intermediate ..........................................................................................................................................................
Morphine ..................................................................................................................................................................................
Thebaine ..................................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................................
Thiafentanil ..............................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Fentanyl ...................................................................................................................................................................................
The company plans to manufacture
the listed controlled substances to make
reference standards which will be
distributed to their customers.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
[FR Doc. 2019–01510 Filed 2–6–19; 8:45 am]
ACTION:
Notice of registration.
BILLING CODE 4410–09–P
The registrant listed below
has applied for and been granted a
SUMMARY:
FR Docket
Sigma Aldrich Co., LLC .................................................................................................................................
83 FR 60903
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
Dated: January 3, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01521 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Research Triangle
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 11, 2019. Such persons
may also file a written request for a
DATES:
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
Company
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic classes of schedule I and II
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security system, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I and II controlled substances
to the above listed company.
9836
9843
1100
1105
9050
9120
9143
9150
9193
9226
9250
9254
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
Published
November 27, 2018.
hearing on the application on or before
March 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2570-2571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01510]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application:
IsoSciences, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 8, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 1, 2017, IsoSciences, LLC, 340 Mathers Road, Ambler,
Pennsylvania 19002, applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................... 1235 I
Methcathinone............................... 1237 I
Lysergic acid diethylamide.................. 7315 I
Marihuana................................... 7360 I
Tetrahydrocannabinols....................... 7370 I
3,4-Methylenedioxyamphetamine............... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine....... 7404 I
5-Methoxy-N-N-dimethyltryptamine............ 7431 I
Alpha-methyltryptamine...................... 7432 I
Bufotenine.................................. 7433 I
Diethyltryptamine........................... 7434 I
Dimethyltryptamine.......................... 7435 I
Psilocybin.................................. 7437 I
Psilocyn.................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
Dihydromorphine............................. 9145 I
Heroin...................................... 9200 I
Nicocodeine................................. 9309 I
Nicomorphine................................ 9312 I
Normorphine................................. 9313 I
Thebacon.................................... 9315 I
Normethadone................................ 9635 I
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
Para-Fluorofentanyl......................... 9812 I
3-Methylfentanyl............................ 9813 I
Alpha-methylfentanyl........................ 9814 I
Acetyl-alpha-methylfentanyl................. 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I
yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl............................ 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Beta-hydroxyfentanyl........................ 9830 I
Beta-hydroxy-3-methylfentanyl............... 9831 I
Alpha-methylthiofentanyl.................... 9832 I
3-Methylthiofentanyl........................ 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl................................ 9835 I
[[Page 2571]]
Beta-hydroxythiofentanyl.................... 9836 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Amphetamine................................. 1100 II
Methamphetamine............................. 1105 II
Codeine..................................... 9050 II
Dihydrocodeine.............................. 9120 II
Oxycodone................................... 9143 II
Hydromorphone............................... 9150 II
Hydrocodone................................. 9193 II
Isomethadone................................ 9226 II
Methadone................................... 9250 II
Methadone intermediate...................... 9254 II
Morphine.................................... 9300 II
Thebaine.................................... 9333 II
Levo-alphacetylmethadol..................... 9648 II
Oxymorphone................................. 9652 II
Thiafentanil................................ 9729 II
Alfentanil.................................. 9737 II
Sufentanil.................................. 9740 II
Carfentanil................................. 9743 II
Fentanyl.................................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
to make reference standards which will be distributed to their
customers.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01510 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P
